Clinical trial
A Phase II Study of RP-6306 in Patients With Advanced Cancer
NCT05605509 is registered in ClinicalTrials.gov with Canadian Cancer Trials Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of RP-6306 in Patients With Advanced Cancer
- Lead sponsor
- Canadian Cancer Trials Group
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 24, 2023
- Completion date
- February 5, 2026
- Enrollment
- 28 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
advanced cancer